InvestmentUpdated on 10 November 2025
NanoCapsule Company
Assistant Professor at NanoCapsule Company
Pavia, Italy
About
The 80% of modern nanomedicines never reach the market because there is no manufacturing process capable of scaling production from the laboratory to industrial levels.
NanoCapsule can provide Microfluidic-based production platforms that can maintain the same formulation across different production scales.
Thanks to the development of multiple platforms, we can address three types of customers: 1) Research laboratories; 2) Pharmaceutical companies; 3) CMOs.
There are devices designed for laboratories and machines designed for industrial production, but there are no solutions that cover all stages of the manufacturing process.
Our Solutions are capable of optimizing the entire production workflow, from laboratory to full-scale manufacturing, including in-line quality control.
We are looking for investors to support our start-up able to speed-up the industrialization process of our novel devices, to reinforce the team from a commercial point of view and to bring to the market our solutions regarding the microfluidics and microfabrication applied to the pharmaceutical world.
Stage
- Seed and Development
- Startup
Applies to
- INDUSTRIAL BIOTECHNOLOGY
- LIFE SCIENCE
- MICRO- AND NANOTECHNOLOGY
- VALUE CHAIN
Similar opportunities
Service
Carlota De Font Degives
Senior Marketing Manager at INBROOLL INDUSTRIES, S.L.
Palol de Revardit GIRONA, Spain
Service
Scale-up your production at small scales
Isabelle FAGGIANELLI
EU Lead Scout - Micro-Assembly at PERCIPIO ROBOTICS
Besançon, France
Product
In-vitro Tool Calibration & Cloud
- E-HEALTH
- MEDICINE
- BIOLOGY / BIOTECHNOLOGY
Barend Smet
President and Co-Founder at Thaumatec Tech Group
Wroclaw, Poland